News

Itch Centers May Be Coming

Publish date: December 2, 2010

 

Dr. Berger has been a consultant for Prescription Solutions and received research funding from GlaxoSmithKline, Clinsys Clinical Research, Merz Pharmaceuticals, and Pharmanet, none of which is relevant to this topic, he said. All the medications for itching that he discussed are used off-label. SDEF and this news organization are owned by Elsevier.

Pages

Recommended Reading

Recommended Approaches to the Adult Woman With Acne
MDedge Internal Medicine
International Dermatologic Surgery Educational Exchange Fund Is Established
MDedge Internal Medicine
PV-10 Melanoma Drug Trial Enrolls Patients in Compassionate Use Program
MDedge Internal Medicine
AADA Continues to Support the Use of Isotretinoin for Severe Acne
MDedge Internal Medicine
Address Adherence at Initial Visit for Acne
MDedge Internal Medicine
Mohs Paste Should Not Be Discounted for Treating Melanoma
MDedge Internal Medicine
New Data Support Safety of Dermatologic Office-Based Surgery
MDedge Internal Medicine
Briakinumab Boosts Quality of Life for Psoriasis Patients
MDedge Internal Medicine
Severe Skin Lesions Complicate Anti-TNF Therapy for IBD
MDedge Internal Medicine
Recommendations for Short Sun Exposure to Boost Vitamin D Criticized
MDedge Internal Medicine